| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/28/2005 | US20050164170 Neurovirulent strain of the west nile virus and uses thereof |
| 07/28/2005 | US20050163805 Orthopoxvirus vectors, genes and products thereof |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163758 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 07/28/2005 | US20050163753 Stable adenoviral vectors and methods for propagation thereof |
| 07/28/2005 | US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/28/2005 | CA2553594A1 Particle-induced ghrelin immune response |
| 07/28/2005 | CA2547511A1 Recombinant icosahedral virus like particle production in pseudomonads |
| 07/27/2005 | EP1556493A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646158A Modified vaccinia virus ankara for the vaccination of neonates |
| 07/27/2005 | CN1644691A Human epidermis factor nucleic sequence and use thereof |
| 07/27/2005 | CN1644686A High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 07/26/2005 | US6921634 Detecting viricidal compounds which inhibit duplication of RNA sequences; fusion proteins; antiproliferative agents |
| 07/26/2005 | US6921535 Attenuated Bovine Respiratory Syncytial virus |
| 07/21/2005 | WO2005066358A1 Method for determining a virus concentration in a liquid biological material |
| 07/21/2005 | WO2005066333A1 Stabilizing compositions for recombinant viruses |
| 07/21/2005 | US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 07/21/2005 | US20050158712 Methods for purifying viral particles for gene therapy |
| 07/21/2005 | US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 07/21/2005 | US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158342 Multi plasmid system for the production of influenza virus |
| 07/21/2005 | US20050158340 Recombinant RSV virus expression systems and vaccines |
| 07/21/2005 | US20050158338 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines |
| 07/21/2005 | US20050158283 Improving adenoviral yields in cell culture systems via maintaining infection temperature below 37 degrees; gene therapy and hetelogous gene transfer; bioreactors |
| 07/21/2005 | CA2548162A1 Serum-free vero cell banking process |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1554401A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 07/20/2005 | EP1554375A2 Adenovirus expressing genes in reverse order and use thereof |
| 07/20/2005 | EP1554301A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 07/20/2005 | EP1259629B1 Recombinant influenza a viruses |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643153A Engineered baculoviruses and their use |
| 07/20/2005 | CN1643139A Bacteriophages |
| 07/20/2005 | CN1642571A Virus-like particles of human papillomavirus |
| 07/20/2005 | CN1640884A Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method |
| 07/20/2005 | CN1211488C Modified plant viruses as vectors of heterologous peptides |
| 07/19/2005 | US6919442 Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses |
| 07/19/2005 | US6919424 Comprises polypeptide for, diagnosis, detection and treatment of cancer |
| 07/19/2005 | US6919085 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 07/19/2005 | US6919084 Antigen strain in vehicle; inducting immunology response |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/14/2005 | WO2005063973A1 Methods and kits for predicting an infectious disease state |
| 07/14/2005 | WO2005063970A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005062820A2 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | WO2005062709A2 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| 07/14/2005 | WO2005027829A3 Method for vaccination of poultry by bacteriophage lysate |
| 07/14/2005 | US20050155113 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 07/14/2005 | US20050153450 Using vector transformation to generate trangenic cells capable of expressing viral sequences and propagate recombinant viral particles |
| 07/14/2005 | US20050153437 Method for controlling biological function with mechanical vibration and device therefor |
| 07/14/2005 | US20050153420 Methods of adenovirus purification |
| 07/14/2005 | US20050153419 Host cells designed for efficient propagation and recovering of viral particles |
| 07/14/2005 | US20050153281 Incubating a cell containing an HCV RNA having a heterologous polynucleotide with a sequence encoding a transactivator; the cell has a transactivated coding region with an operator sequence linked to it that encodes a detectable marker; transactivator alters transcription of the coding region |
| 07/14/2005 | US20050153279 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152918 Identifying whether an egg at day eleven of incubation (day-11) contains a live embryo by illuminaion with light from a light emitting diode (LED) at 650 nm-850 nm, injecting live egg with flu virus and harvesting amniotic fluid which has flu vaccine |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | DE10131145B4 Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen Composition for cell-specific transfer of drugs |
| 07/14/2005 | CA2551489A1 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | CA2551026A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | CA2541135A1 Methods and kits for predicting an infectious disease state |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553169A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 07/13/2005 | EP1551961A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | CN2709453Y Industrial fermentation exhaust debacteriophages device |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639327A Recovery of viruses |
| 07/13/2005 | CN1639326A High throughput system for producing recombinant viruses using site-specific recombination |
| 07/13/2005 | CN1639325A A method for producing recombinant viruses using site-specific recombination |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1638795A MVA expressing modified HIV envelope, GAG, and pol genes |
| 07/13/2005 | CN1637140A Method of culturing and propagating poliomyelitis virus with human embryo lung diploid |
| 07/13/2005 | CN1637139A Bean hawkmoth baculovirus and its application in preventing and killing bean hawkmoth larva |
| 07/13/2005 | CN1637138A Silkworm nuclear polyhedron virus and its prepn process and application in gene expression |
| 07/13/2005 | CN1210405C Expression quantity of increasing insect rhabdovirus system exogenous gene by utilizing insect hormone |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
| 07/12/2005 | CA2503512A1 Avian pneumovirus genes, recombinant avian pneumovirus and methods of making |
| 07/07/2005 | WO2005061698A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | WO2005042728A3 Immortalized avian cell lines for virus production |
| 07/07/2005 | WO2005035556A3 Sars-coronavirus virus-like particles and methods of use |
| 07/07/2005 | US20050147623 Recombinant parainfluenza virus expression systems and vaccines |
| 07/07/2005 | US20050147622 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 07/07/2005 | CA2551009A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | CA2545696A1 An oncolytic adenovirus |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549761A1 Methods and compositions for the modification of nucleic acids |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549751A2 Recombinant adenoviral vectors and applications thereof |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549140A2 Production of peptides in plants as viral coat protein fusions |
| 07/06/2005 | EP1017837B1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |